Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122307573 | 12230757 | 3 | F | 20151230 | 20160803 | 20160401 | 20160912 | PER | US-JNJFOC-20160301295 | JANSSEN | 53.41 | YR | A | F | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122307573 | 12230757 | 1 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 22406 | 20 | MG | TABLET | |||||
| 122307573 | 12230757 | 2 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | 1 TABLET DAILY | Y | 0 | TABLET | ||||||||
| 122307573 | 12230757 | 3 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
| 122307573 | 12230757 | 4 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
| 122307573 | 12230757 | 5 | C | OXYCODONE | OXYCODONE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 122307573 | 12230757 | 6 | C | VALIUM | DIAZEPAM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 122307573 | 12230757 | 7 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 122307573 | 12230757 | 8 | C | DULOXETINE HCL | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 122307573 | 12230757 | 9 | C | BUPROPION. | BUPROPION | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 122307573 | 12230757 | 10 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 122307573 | 12230757 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 122307573 | 12230757 | 12 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 122307573 | 12230757 | 13 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 122307573 | 12230757 | 14 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122307573 | 12230757 | 1 | Deep vein thrombosis |
| 122307573 | 12230757 | 2 | Product used for unknown indication |
| 122307573 | 12230757 | 3 | Product used for unknown indication |
| 122307573 | 12230757 | 4 | Product used for unknown indication |
| 122307573 | 12230757 | 5 | Product used for unknown indication |
| 122307573 | 12230757 | 6 | Product used for unknown indication |
| 122307573 | 12230757 | 7 | Product used for unknown indication |
| 122307573 | 12230757 | 8 | Product used for unknown indication |
| 122307573 | 12230757 | 9 | Product used for unknown indication |
| 122307573 | 12230757 | 10 | Product used for unknown indication |
| 122307573 | 12230757 | 11 | Product used for unknown indication |
| 122307573 | 12230757 | 12 | Product used for unknown indication |
| 122307573 | 12230757 | 13 | Product used for unknown indication |
| 122307573 | 12230757 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122307573 | 12230757 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122307573 | 12230757 | Shock haemorrhagic | |
| 122307573 | 12230757 | Upper gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122307573 | 12230757 | 1 | 20151201 | 20151231 | 0 |